US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

IMAB

I MAB (IMAB)

I MAB

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IMAB

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/06	20 : 14	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/06/06	20 : 00	PR Newswire (US)	I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer	NASDAQ:IMAB	I MAB
2024/06/05	20 : 11	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/06/05	20 : 00	PR Newswire (US)	I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers	NASDAQ:IMAB	I MAB
2024/05/31	06 : 33	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:IMAB	I MAB
2024/05/24	06 : 11	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/05/24	06 : 05	GlobeNewswire Inc.	I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024	NASDAQ:IMAB	I MAB
2024/05/22	20 : 00	PR Newswire (US)	I-Mab to Participate at the Jefferies Global Healthcare Conference	NASDAQ:IMAB	I MAB
2024/04/30	20 : 00	PR Newswire (US)	I-MAB Filed 2023 Annual Report on Form 20-F	NASDAQ:IMAB	I MAB
2024/04/05	20 : 00	PR Newswire (US)	I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:IMAB	I MAB
2024/04/03	05 : 01	PR Newswire (US)	I-Mab Announces Closing of the Divestiture of Business Operations in China	NASDAQ:IMAB	I MAB
2024/03/15	06 : 00	PR Newswire (US)	I-Mab Reports Full Year 2023 Financial Results and Business Update	NASDAQ:IMAB	I MAB
2024/02/10	06 : 01	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IMAB	I MAB
2024/02/08	20 : 07	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
2024/02/07	20 : 52	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/02/07	20 : 00	PR Newswire (US)	I-Mab Signs Agreement to Divest its Assets and Business Operations in China	NASDAQ:IMAB	I MAB
2024/02/07	10 : 55	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:IMAB	I MAB
2024/02/06	20 : 34	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/01/05	20 : 21	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
2024/01/03	07 : 08	Dow Jones News	ADRs Slump; FLJ Group Declines 21%	NASDAQ:IMAB	I MAB
2023/12/29	20 : 12	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
2023/12/26	20 : 22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
2023/12/02	04 : 41	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:IMAB	I MAB
2023/11/16	20 : 43	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
2023/11/06	22 : 00	PR Newswire (US)	I-Mab Announces Participation at Jefferies and Piper Conferences in November	NASDAQ:IMAB	I MAB
2023/11/02	21 : 00	PR Newswire (US)	Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)	NASDAQ:IMAB	I MAB
2023/11/01	21 : 00	PR Newswire (US)	I-Mab Announces Poster Presentations of 4-1BB Bispecific Antibody Portfolio at SITC 2023	NASDAQ:IMAB	I MAB
2023/10/16	21 : 00	PR Newswire (US)	I-Mab Announces Phase 1 Data of Givastomig at ESMO 2023	NASDAQ:IMAB	I MAB
2023/10/11	00 : 04	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
2023/10/10	21 : 24	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB

Showing the most relevant articles for your search:NASDAQ:IMAB

1 2 3 4 5 6 7 8 9 10 次へ >>

GraniteShares 3x Short P...

RAMP DEFI [OLD]

Banco Santander

Madeira Bond 21 March 2035

African Gold Acquisition (CE)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約